Paper41760342
Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.
Lin CC and 6 others. In Vivo, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report. Papers, record 41760342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41760342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sjogren's Syndrome | Major topic |
| Behcet Syndrome | Major topic |
| Oral Ulcer | Major topic |
| Hydrogen | Major topic |
| T-Lymphocytes | Major topic |
| Antibodies, Antinuclear | Major topic |
| Humans | |
| Female | |
| Aged | |
| Biomarkers | |
| Treatment Outcome |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35038644 | Immunopathogenesis of Behçet's disease and treatment modalities. | Semin Arthritis Rheum | 2022 | https://conductscience.org/library/papers/35038644 | PubMed |
| 2 | 8814751 | Insufficient expression of Fas antigen on helper T cells in Behçet's disease. | Br J Ophthalmol | 1996 | https://conductscience.org/library/papers/8814751 | PubMed |
| 3 | 8246006 | Behçet's disease and Sjögren syndrome in a patient with HTLV-I-associated myelopathy. | J Neurol Sci | 1993 | https://conductscience.org/library/papers/8246006 | PubMed |
| 4 | 39477378 | Molecular Hydrogen Therapy in Sjögren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell. | In Vivo | 2024 | https://conductscience.org/library/papers/39477378 | PubMed |
| 5 | 20012976 | [Epidemiology of primary Sjörgren's syndrome]. | Z Rheumatol | 2010 | https://conductscience.org/library/papers/20012976 | PubMed |
| 6 | 40812663 | Hydrogen protects against autoimmune myocarditis by inhibiting necroptosis via the TNF/TNFR1 signalling pathway. | Clin Immunol | 2025 | https://conductscience.org/library/papers/40812663 | PubMed |
| 7 | 22326205 | Pathogenesis of Sjögren's syndrome: what we know and what we should learn. | J Autoimmun | 2012 | https://conductscience.org/library/papers/22326205 | PubMed |
| 8 | 27351485 | Behcet's disease: epidemiology, clinical manifestations, and diagnosis. | Expert Rev Clin Immunol | 2017 | https://conductscience.org/library/papers/27351485 | PubMed |
| 9 | 32699287 | Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults: a randomized, double-blind, controlled trial. | Sci Rep | 2020 | https://conductscience.org/library/papers/32699287 | PubMed |
| 10 | 29514034 | Primary Sjögren's Syndrome. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29514034 | PubMed |
| 11 | 17004051 | [Sjögren's syndrome. Current aspects from a rheumatological point of view]. | Z Rheumatol | 2006 | https://conductscience.org/library/papers/17004051 | PubMed |
| 12 | 38826750 | Hydrogen therapy promotes macrophage polarization to the M2 subtype in radiation lung injury by inhibiting the NF-κB signalling pathway. | Heliyon | 2024 | https://conductscience.org/library/papers/38826750 | PubMed |
| 13 | 39740897 | Molecular Hydrogen as a Potential Adjunctive Therapy to Improve Renal Function and Reduce Fatigue in an Elderly Patient With Chronic Comorbidities: A Case Report. | In Vivo | 2025 | https://conductscience.org/library/papers/39740897 | PubMed |
| 14 | 19269776 | [Primary Gougerot-Sjögren syndrome and Behçet disease: association or coincidence?]. | Presse Med | 2009 | https://conductscience.org/library/papers/19269776 | PubMed |
| 15 | 28610655 | The Diagnosis and Treatment of Sjögren's Syndrome. | Dtsch Arztebl Int | 2017 | https://conductscience.org/library/papers/28610655 | PubMed |
| 16 | 39477420 | Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells. | In Vivo | 2024 | https://conductscience.org/library/papers/39477420 | PubMed |
| 17 | 39290700 | Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment. | Front Immunol | 2024 | https://conductscience.org/library/papers/39290700 | PubMed |
| 18 | 4125812 | Sjögren's syndrome in Behçet's disease. | Lancet | 1973 | https://conductscience.org/library/papers/4125812 | PubMed |
| 19 | 25747486 | Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications. | Methods Enzymol | 2015 | https://conductscience.org/library/papers/25747486 | PubMed |
| 20 | 9636948 | Joint manifestations in Behçet's disease. A review of 340 cases. | Rev Rhum Engl Ed | 1998 | https://conductscience.org/library/papers/9636948 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42553344 | The "two flowers therapy": clinical efficacy and mechanisms of a total glucosides of paeony -colchicine dual-drugs for Behçet's disease derived from Chinese physicians' medication experience. | Front Immunol | 2026 | https://conductscience.org/library/papers/42553344 |
Source PubMed
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41760342
GET https://conductscience.org/api/papers/v1/41760342/references?page=2